+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gene Knockdown Service Market - Global Forecast 2025-2030- Product Image
Gene Knockdown Service Market - Global Forecast 2025-2030- Product Image
Sale

Gene Knockdown Service Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 193 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6140055
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Gene knockdown services are experiencing growing adoption as organizations seek precise solutions for functional genomics research and streamlined therapeutic development. This market presents tailored offerings and robust workflows, positioning providers to meet the evolving requirements of senior decision-makers in research institutions, biotechnology companies, and the pharmaceutical sector.

Market Snapshot: Gene Knockdown Services

The global gene knockdown services market is characterized by consistent expansion, underpinned by increasing investment in R&D, advancements in delivery platforms, and a rising demand for accurate gene modulation techniques. Recognized providers deliver comprehensive solutions that address challenges across target discovery, validation, and therapeutic pipelines. Key players, including Thermo Fisher Scientific Inc., Merck KGaA, and QIAGEN N.V., are continually broadening their capabilities. Strategic collaborations, a focus on next-generation delivery technologies, and the integration of predictive analytics are reshaping competitive dynamics, with growth opportunities visible across the Americas, Europe, Middle East and Africa, and Asia-Pacific.

Scope & Segmentation of Gene Knockdown Services

This report offers granular coverage of the market’s full spectrum, addressing multiple service and technology segments, regional developments, and end-user dynamics.

  • Product Types: Antisense oligonucleotide services (gapmers, steric blockers), microRNA interventions (inhibitors, mimics), shRNA (lentiviral, plasmid vectors), and siRNA (chemically modified, unmodified).
  • Delivery Methods: Electroporation (bulk, microfluidic), lipid-based transfection (cationic, ionizable lipid, peptide formulations), nanoparticle-mediated delivery, and viral vectors (adeno-associated, adenovirus, lentivirus).
  • End Users: Academic research institutes, biotechnology companies (established and start-ups), global and regional contract research organizations, large and mid-size pharmaceutical companies.
  • Applications: Biomarker validation (diagnostic, prognostic markers), drug discovery (lead optimization, target validation), functional genomics (expression profiling, gene function analysis), and therapeutic development (preclinical, clinical trials).
  • Therapeutic Areas: Cardiovascular diseases, infectious diseases, neurology, oncology.
  • Geographic Regions: Americas (United States, Canada, Latin America), Europe, Middle East & Africa, Asia-Pacific (including China, India, Japan, and more).
  • Leading Companies: Thermo Fisher Scientific Inc., Merck KGaA, QIAGEN N.V., PerkinElmer, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, GenScript Biotech Corporation, Takara Bio Inc., Azenta, Inc.

Key Takeaways for Decision-Makers

  • Next-generation gene knockdown services are leveraging advanced microfluidic, nanoparticle, and engineered viral delivery systems for increased efficiency and reduced cytotoxicity.
  • End-to-end solutions, from sequence design through in vitro and in vivo validation, are streamlining workflow integration and accelerating project delivery for strategic clients.
  • Investment in bioinformatics pipelines is refining target specificity, minimizing off-target effects, and supporting high-throughput screening in therapeutic programs.
  • Collaborative models between service providers, manufacturers, and research institutions are becoming a primary route to optimizing technology adoption and workflow innovation.
  • Regionalized manufacturing and supply chain adaptations are supporting resilience, particularly in response to evolving regulatory and trade landscapes.

United States Tariff Impact on Gene Knockdown Service Market

The 2025 implementation of new United States tariffs has introduced additional cost and supply chain challenges for gene knockdown service providers and their clients. Increased import duties on international reagents and equipment have resulted in revised procurement practices, a strengthened focus on domestic sourcing, and growing collaboration with regional manufacturers. Flexible pricing models and enhanced transparency now play a critical role in maintaining competitiveness and service accessibility.

Methodology & Data Sources

This research combines structured primary interviews with senior scientists, R&D leaders, and procurement managers, together with secondary reviews of scientific publications, regulatory files, and industry reports. Cross-validation and data reconciliation ensure the reliability of qualitative and quantitative insights, supporting the accuracy of reported market segmentation and trends.

Why This Report Matters

  • Senior leaders can leverage actionable intelligence to optimize gene knockdown project investments and select best-fit service partners.
  • The report delivers visibility into evolving technology platforms, regulatory shifts, and regional market nuances, supporting informed forecast planning.
  • Detailed segmentation and competitor analysis enable benchmarking against top innovators, helping chart targeted growth and operational strategies.

Conclusion

Advancements in delivery systems, analytics, and bioinformatics are positioning gene knockdown services as an essential enabler for future research and therapeutic discovery. Stakeholders equipped with strategic insights from this report will be well prepared to navigate an evolving, opportunity-rich market environment.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of CRISPRi techniques with high-throughput screening for accelerated target validation
5.2. Development of nanoparticle-mediated siRNA delivery systems to improve gene silencing efficiency in vivo
5.3. Partnerships between biotech startups and academic institutions to expand custom gene knockdown libraries for rare disease research
5.4. Emergence of AI-driven design tools optimizing shRNA sequences for minimal off-target effects and specificity
5.5. Commercial launches of multiplexed siRNA platforms enabling simultaneous knockdown of multiple genes in cell-based assays
5.6. Advancements in organoid-based gene knockdown models facilitating translational research into complex tissue biology
5.7. Regulatory adaptation to streamline approval pathways for gene knockdown therapeutics and reagents in global markets
5.8. Expansion of custom RNAi screening services offering integrated bioinformatics support for target discovery pipelines
5.9. Rising adoption of inducible knockdown systems enabling temporal control of gene expression in functional studies
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Gene Knockdown Service Market, by Product Type
8.1. Introduction
8.2. Antisense Oligonucleotide
8.2.1. Gapmers
8.2.2. Steric Blockers
8.3. MicroRNA
8.3.1. Inhibitor
8.3.2. Mimic
8.4. ShRNA
8.4.1. Lentiviral Vector
8.4.2. Plasmid Vector
8.5. SiRNA
8.5.1. Chemically Modified
8.5.2. Unmodified
9. Gene Knockdown Service Market, by Delivery Method
9.1. Introduction
9.2. Electroporation
9.2.1. Bulk Electroporation
9.2.2. Microfluidic Electroporation
9.3. Lipid-Based Transfection
9.3.1. Cationic Lipids
9.3.2. Ionizable Lipids
9.3.3. Peptide Formulations
9.4. Nanoparticle-Based Delivery
9.5. Viral Vector
9.5.1. Adeno-Associated Virus
9.5.2. Adenovirus
9.5.3. Lentivirus
10. Gene Knockdown Service Market, by End User
10.1. Introduction
10.2. Academic Research Institutes
10.2.1. Research Centers
10.2.2. Universities
10.3. Biotechnology Companies
10.3.1. Established Biotechnology
10.3.2. Start-Up Biotechnology
10.4. Contract Research Organizations
10.4.1. Global CROs
10.4.2. Regional CROs
10.5. Pharmaceutical Companies
10.5.1. Large Pharmaceutical
10.5.2. Mid-Size Pharmaceutical
11. Gene Knockdown Service Market, by Application
11.1. Introduction
11.2. Biomarker Validation
11.2.1. Diagnostic Markers
11.2.2. Prognostic Markers
11.3. Drug Discovery
11.3.1. Lead Optimization
11.3.2. Target Validation
11.4. Functional Genomics
11.4.1. Expression Profiling
11.4.2. Gene Function Analysis
11.5. Therapeutic Development
11.5.1. Clinical Trials
11.5.2. Preclinical Studies
12. Gene Knockdown Service Market, by Therapeutic Area
12.1. Introduction
12.2. Cardiovascular Diseases
12.2.1. Atherosclerosis
12.2.2. Heart Failure
12.3. Infectious Diseases
12.3.1. Bacterial Infections
12.3.2. Viral Infections
12.4. Neurology
12.4.1. Alzheimer's Disease
12.4.2. Parkinson's Disease
12.5. Oncology
12.5.1. Breast Cancer
12.5.2. Leukemia
12.5.3. Lung Cancer
13. Americas Gene Knockdown Service Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Gene Knockdown Service Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Gene Knockdown Service Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Thermo Fisher Scientific Inc.
16.3.2. Merck KGaA
16.3.3. QIAGEN N.V.
16.3.4. PerkinElmer, Inc.
16.3.5. Agilent Technologies, Inc.
16.3.6. Bio-Rad Laboratories, Inc.
16.3.7. Danaher Corporation
16.3.8. GenScript Biotech Corporation
16.3.9. Takara Bio Inc.
16.3.10. Azenta, Inc.
17. Research AI18. Research Statistics19. Research Contacts20. Research Articles21. Appendix
List of Figures
FIGURE 1. GENE KNOCKDOWN SERVICE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY DELIVERY METHOD, 2024 VS 2030 (%)
FIGURE 8. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY DELIVERY METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 14. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS GENE KNOCKDOWN SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS GENE KNOCKDOWN SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES GENE KNOCKDOWN SERVICE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES GENE KNOCKDOWN SERVICE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA GENE KNOCKDOWN SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA GENE KNOCKDOWN SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC GENE KNOCKDOWN SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC GENE KNOCKDOWN SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. GENE KNOCKDOWN SERVICE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. GENE KNOCKDOWN SERVICE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. GENE KNOCKDOWN SERVICE MARKET: RESEARCHAI
FIGURE 26. GENE KNOCKDOWN SERVICE MARKET: RESEARCHSTATISTICS
FIGURE 27. GENE KNOCKDOWN SERVICE MARKET: RESEARCHCONTACTS
FIGURE 28. GENE KNOCKDOWN SERVICE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. GENE KNOCKDOWN SERVICE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY ANTISENSE OLIGONUCLEOTIDE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY ANTISENSE OLIGONUCLEOTIDE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY GAPMERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY GAPMERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY STERIC BLOCKERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY STERIC BLOCKERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY ANTISENSE OLIGONUCLEOTIDE, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY ANTISENSE OLIGONUCLEOTIDE, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY MICRORNA, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY MICRORNA, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY INHIBITOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY INHIBITOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY MIMIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY MIMIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY MICRORNA, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY MICRORNA, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY SHRNA, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY SHRNA, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY LENTIVIRAL VECTOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY LENTIVIRAL VECTOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY PLASMID VECTOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY PLASMID VECTOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY SHRNA, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY SHRNA, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY SIRNA, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY SIRNA, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY CHEMICALLY MODIFIED, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY CHEMICALLY MODIFIED, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY UNMODIFIED, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY UNMODIFIED, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY SIRNA, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY SIRNA, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY ELECTROPORATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY ELECTROPORATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY BULK ELECTROPORATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY BULK ELECTROPORATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY MICROFLUIDIC ELECTROPORATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY MICROFLUIDIC ELECTROPORATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY ELECTROPORATION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY ELECTROPORATION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY LIPID-BASED TRANSFECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY LIPID-BASED TRANSFECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY CATIONIC LIPIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY CATIONIC LIPIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY IONIZABLE LIPIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY IONIZABLE LIPIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY PEPTIDE FORMULATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY PEPTIDE FORMULATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY LIPID-BASED TRANSFECTION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY LIPID-BASED TRANSFECTION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY NANOPARTICLE-BASED DELIVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY NANOPARTICLE-BASED DELIVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY VIRAL VECTOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY VIRAL VECTOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY ADENO-ASSOCIATED VIRUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY ADENO-ASSOCIATED VIRUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY ADENOVIRUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY ADENOVIRUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY LENTIVIRUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY LENTIVIRUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY VIRAL VECTOR, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY VIRAL VECTOR, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY RESEARCH CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY RESEARCH CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY UNIVERSITIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY UNIVERSITIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY ESTABLISHED BIOTECHNOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY ESTABLISHED BIOTECHNOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY START-UP BIOTECHNOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY START-UP BIOTECHNOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY GLOBAL CROS, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY GLOBAL CROS, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY REGIONAL CROS, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY REGIONAL CROS, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY LARGE PHARMACEUTICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY LARGE PHARMACEUTICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY MID-SIZE PHARMACEUTICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY MID-SIZE PHARMACEUTICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY BIOMARKER VALIDATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY BIOMARKER VALIDATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY DIAGNOSTIC MARKERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY DIAGNOSTIC MARKERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY PROGNOSTIC MARKERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY PROGNOSTIC MARKERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY BIOMARKER VALIDATION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY BIOMARKER VALIDATION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY LEAD OPTIMIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY LEAD OPTIMIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY TARGET VALIDATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY TARGET VALIDATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY FUNCTIONAL GENOMICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY FUNCTIONAL GENOMICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY EXPRESSION PROFILING, BY REGION, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY EXPRESSION PROFILING, BY REGION, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY GENE FUNCTION ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY GENE FUNCTION ANALYSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY FUNCTIONAL GENOMICS, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY FUNCTIONAL GENOMICS, 2025-2030 (USD MILLION)
TABLE 135. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY THERAPEUTIC DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 136. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY THERAPEUTIC DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 137. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 138. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 139. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY PRECLINICAL STUDIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 140. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY PRECLINICAL STUDIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 141. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY THERAPEUTIC DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 142. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY THERAPEUTIC DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 143. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 144. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 145. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 146. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 147. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY ATHEROSCLEROSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 148. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY ATHEROSCLEROSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 149. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY HEART FAILURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 150. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY HEART FAILURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 151. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2024 (USD MILLION)
TABLE 152. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2025-2030 (USD MILLION)
TABLE 153. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 154. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 155. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY BACTERIAL INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 156. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY BACTERIAL INFECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 157. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY VIRAL INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 158. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY VIRAL INFECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 159. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 160. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 161. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 162. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 163. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY ALZHEIMER'S DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 164. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY ALZHEIMER'S DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 165. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY PARKINSON'S DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 166. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY PARKINSON'S DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 167. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 168. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 169. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 170. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 171. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 172. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY BREAST CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 173. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY LEUKEMIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 174. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY LEUKEMIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 175. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 176. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY LUNG CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 177. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 178. GLOBAL GENE KNOCKDOWN SERVICE MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 179. AMERICAS GENE KNOCKDOWN SERVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 180. AMERICAS GENE KNOCKDOWN SERVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 181. AMERICAS GENE KNOCKDOWN SERVICE MARKET SIZE, BY ANTISENSE OLIGONUCLEOTIDE, 2018-2024 (USD MILLION)
TABLE 182. AMERICAS GENE KNOCKDOWN SERVICE MARKET SIZE, BY ANTISENSE OLIGONUCLEOTIDE, 2025-2030 (USD MILLION)
TABLE 183. AMERICAS GENE KNOCKDOWN SERVICE MARKET SIZE, BY MICRORNA, 2018-2024 (USD MILLION)
TABLE 184. AMERICAS GENE KNOCKDOWN SERVICE MARKET SIZE, BY MICRORNA, 2025-2030 (USD MILLION)
TABLE 185. AMERICAS GENE KNOCKDOWN SERVICE MARKET SIZE, BY SHRNA, 2018-2024 (USD MILLION)
TABLE 186. AMERICAS GENE KNOCKDOWN SERVICE MARKET SIZE, BY SHRNA, 2025-2030 (USD MILLION)
TABLE 187. AMERICAS GENE KNOCKDOWN SERVICE MARKET SIZE, BY SIRNA, 2018-2024 (USD MILLION)
TABLE 188. AMERICAS GENE KNOCKDOWN SERVICE MARKET SIZE, BY SIRNA, 2025-2030 (USD MILLION)
TABLE 189. AMERICAS GENE KNOCKDOWN SERVICE MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 190. AMERICAS GENE KNOCKDOWN SERVICE MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 191. AMERICAS GENE KNOCKDOWN SERVICE MARKET SIZE, BY ELECTROPORATION, 2018-2024 (USD MILLION)
TABLE 192. AMERICAS GENE KNOCKDOWN SERVICE MARKET SIZE, BY ELECTROPORATION, 2025-2030 (USD MILLION)
TABLE 193. AMERICAS GENE KNOCKDOWN SERVICE MARKET SIZE, BY LIPID-BASED TRANSFECTION, 2018-2024 (USD MILLION)
TABLE 194. AMERICAS GENE KNOCKDOWN SERVICE MARKET SIZE, BY LIPID-BASED TRANSFECTION, 2025-2030 (USD MILLION)
TABLE 195. AMERICAS GENE KNOCKDOWN SERVICE MARKET SIZE, BY VIRAL VECTOR, 2018-2024 (USD MILLION)
TABLE 196. AMERICAS GENE KNOCKDOWN SERVICE MARKET SIZE, BY VIRAL VECTOR, 2025-2030 (USD MILLION)
TABLE 197. AMERICAS GENE KNOCKDOWN SERVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 198. AMERICAS GENE KNOCKDOWN SERVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 199. AMERICAS GENE KNOCKDOWN SERVICE MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 200. AMERICAS GENE KNOCKDOWN SERVICE MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 201. AMERICAS GENE KNOCKDOWN SERVICE MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 202. AMERICAS GENE KNOCKDOWN SERVICE MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 203. AMERICAS GENE KNOCKDOWN SERVICE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 204. AMERICAS GENE KNOCKDOWN SERVICE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 205. AMERICAS GENE KNOCKDOWN SERVICE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 206. AMERICAS GENE KNOCKDOWN SERVICE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 207. AMERICAS GENE KNOCKDOWN SERVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 208. AMERICAS GENE KNOCKDOWN SERVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 209. AMERICAS GENE KNOCKDOWN SERVICE MARKET SIZE, BY BIOMARKER VALIDATION, 2018-2024 (USD MILLION)
TABLE 210. AMERICAS GENE KNOCKDOWN SERVICE MARKET SIZE, BY BIOMARKER VALIDATION, 2025-2030 (USD MILLION)
TABLE 211. AMERICAS GENE KNOCKDOWN SERVICE MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 212. AMERICAS GENE KNOCKDOWN SERVICE MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 213. AMERICAS GENE KNOCKDOWN SERVICE MARKET SIZE, BY FUNCTIONAL GENOMICS, 2018-2024 (USD MILLION)
TABLE 214. AMERICAS GENE KNOCKDOWN SERVICE MARKET SIZE, BY FUNCTIONAL GENOMICS, 2025-2030 (USD MILLION)
TABLE 215. AMERICAS GENE KNOCKDOWN SERVICE MARKET SIZE, BY THERAPEUTIC DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 216. AMERICAS GENE KNOCKDOWN SERVICE MARKET SIZE, BY THERAPEUTIC DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 217. AMERICAS GENE KNOCKDOWN SERVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 218. AMERICAS GENE KNOCKDOWN SERVICE MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 219. AMERICAS GENE KNOCKDOWN SERVICE MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2024 (USD MILLION)
TABLE 220. AMERICAS GENE KNOCKDOWN SERVICE MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2025-2030 (USD MILLION)
TABLE 221. AMERICAS GENE KNOCKDOWN SERVICE MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 222. AMERICAS GENE KNOCKDOWN SERVICE MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 223. AMERICAS GENE KNOCKDOWN SERVICE MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 224. AMERICAS GENE KNOCKDOWN SERVICE MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 225. AMERICAS GENE KNOCKDOWN SERVICE MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 226. AMERICAS GENE KNOCKDOWN SERVICE MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 227. AMERICAS GENE KNOCKDOWN SERVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 228. AMERICAS GENE KNOCKDOWN SERVICE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 229. UNITED STATES GENE KNOCKDOWN SERVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 230. UNITED STATES GENE KNOCKDOWN SERVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 231. UNITED STATES GENE KNOCKDOWN SERVICE MARKET SIZE, BY ANTISENSE OLIGONUCLEOTIDE, 2018-2024 (USD MILLION)
TABLE 232. UNITED STATES GENE KNOCKDOWN SERVICE MARKET SIZE, BY ANTISENSE OLIGONUCLEOTIDE, 2025-2030 (USD MILLION)
TABLE 233. UNITED STATES GENE KNOCKDOWN SERVICE MARKET SIZE, BY MICRORNA, 2018-2024 (USD MILLION)
TABLE 234. UNITED STATES GENE KNOCKDOWN SERVICE MARKET SIZE, BY MICRORNA, 2025-2030 (USD MILLION)
TABLE 235. UNITED STATES GENE KNOCKDOWN SERVICE MARKET SIZE, BY SHRNA, 2018-2024 (USD MILLION)
TABLE 236. UNITED STATES GENE KNOCKDOWN SERVICE MARKET SIZE, BY SHRNA, 2025-2030 (USD MILLION)
TABLE 237. UNITED STATES GENE KNOCKDOWN SERVICE MARKET SIZE, BY SIRNA, 2018-2024 (USD MILLION)
TABLE 238. UNITED STATES GENE KNOCKDOWN SERVICE MARKET SIZE, BY SIRNA, 2025-2030 (USD MILLION)
TABLE 239. UNITED STATES GENE KNOCKDOWN SERVICE MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 240. UNITED STATES GENE KNOCKDOWN SERVICE MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 241. UNITED STATES GENE KNOCKDOWN SERVICE MARKET SIZE, BY ELECTROPORATION, 2018-2024 (USD MILLION)
TABLE 242. UNITED STATES GENE KNOCKDOWN SERVICE MARKET SIZE, BY ELECTROPORATION, 2025-2030 (USD MILLION)
TABLE 243. UNITED STATES GENE KNOCKDOWN SERVICE MARKET SIZE, BY LIPID-BASED TRANSFECTION, 2018-2024 (USD MILLION)
TABLE 244. UNITED STATES GENE KNOCKDOWN SERVICE MARKET SIZE, BY LIPID-BASED TRANSFECTION, 2025-2030 (USD MILLION)
TABLE 245. UNITED STATES GENE KNOCKDOWN SERVICE MARKET SIZE, BY VIRAL VECTOR, 2018-2024 (USD MILLION)
TABLE 246. UNITED STATES GENE KNOCKDOWN SERVICE MARKET SIZE, BY VIRAL VECTOR, 2025-2030 (USD MILLION)
TABLE 247. UNITED STATES GENE KNOCKDOWN SERVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 248. UNITED STATES GENE KNOCKDOWN SERVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 249. UNITED STATES GENE KNOCKDOWN SERVICE MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 250. UNITED STATES GENE KNOCKDOWN SERVICE MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 251. UNITED STATES GENE KNOCKDOWN SERVICE MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 252. UNITED STATES GENE KNOCKDOWN SERVICE MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 253. UNITED STATES GENE KNOCKDOWN SERVICE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 254. UNITED STATES GENE KNOCKDOWN SERVICE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 255. UNITED STATES GENE KNOCKDOWN SERVICE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 256. UNITED STATES GENE KNOCKDOWN SERVICE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 257. UNITED STATES GENE KNOCKDOWN SERVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 258. UNITED STATES GENE KNOCKDOWN SERVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 259. UNITED STATES GENE KNOCKDOWN SERVICE MARKET SIZE, BY BIOMARKER VALIDATION, 2018-2024 (USD MILLION)
TABLE 260. UNITED STATES GENE KNOCKDOWN SERVICE MARKET SIZE, BY BIOMARKER VALIDATION, 2025-2030 (USD MILLION)
TABLE 261. UNITED STATES GENE KNOCKDOWN SERVICE MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 262. UNITED STATES GENE KNOCKDOWN SERVICE MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 263. UNITED STATES GENE KNOCKDOWN SERVICE MARKET SIZE, BY FUNCTIONAL GENOMICS, 2018-2024 (USD MILLION)
TABLE 264. UNITED STATES GENE KNOCKDOWN SERVICE MARKET SIZE, BY FUNCTIONAL GENOMICS, 2025-2030 (USD MILLION)
TABLE 265. UNITED STATES GENE KNOCKDOWN SERVICE MARKET SIZE, BY THERAPEUTIC DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 266. UNITED STATES GENE KNOCKDOWN SERVICE MARKET SIZE, BY THERAPEUTIC DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 267. UNITED STATES GENE KNOCKDOWN SERVICE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 268. UNITED STATES GENE KNOCKDOWN SERVICE MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 269. UNITED STATES GENE KNOCKDOWN SERVICE MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2024 (USD MILLION)
TABLE 270. UNITED STATES GENE KNOCKDOWN SERVICE MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2025-2030 (USD MILLION)
TABLE 271. UNITED STATES GENE KNOCKDOWN SERVICE MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 272. UNITED STATES GENE KNOCKDOWN SERVICE MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 273. UNITED STATES GENE KNOCKDOWN SERVICE MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 274. UNITED STATES GENE KNOCKDOWN SERVICE MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 275. UNITED STATES GENE KNOCKDOWN SERVICE MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 276. UNITED STATES GENE KNOCKDOWN SERVICE MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 277. UNITED STATES GENE KNOCKDOWN SERVICE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 278. UNITED STATES GENE KNOCKDOWN SERVICE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 279. CANADA GENE KNOCKDOWN SERVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 280. CANADA GENE KNOCKDOWN SERVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 281. CANADA GENE KNOCKDOWN SERVICE MARKET SIZE, BY ANTISENSE OLIGONUCLEOTIDE, 2018-2024 (USD MILLION)
TABLE 282. CANADA GENE KNOCKDOWN SERVICE MARKET SIZE, BY ANTISENSE OLIGONUCLEOTIDE, 2025-2030 (USD MILLION)
TABLE 283. CANADA GENE KNOCKDOWN SERVICE MARKET SIZE, BY MICRORNA, 2018-2024 (USD MILLION)
TABLE 284. CANADA GENE KNOCKDOWN SERVICE MARKET SIZE, BY MICRORNA, 2025-2030 (USD MILLION)
TABLE 285. CANADA GENE KNOCKDOWN SERVICE MARKET SIZE, BY SHRNA, 2018-2024 (USD MILLION)
TABLE 286. CANADA GENE KNOCKDOWN SERVICE MARKET SIZE, BY SHRNA, 2025-2030 (USD MILLION)
TABLE 287. CANADA GENE KNOCKDOWN SERVICE MARKET SIZE, BY SIRNA, 2018-2024 (USD MILLION)
TABLE 288. CANADA GENE KNOCKDOWN SERVICE MARKET SIZE, BY SIRNA, 2025-2030 (USD MILLION)
TABLE 289. CANADA GENE KNOCKDOWN SERVICE MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 290. CANADA GENE KNOCKDOWN SERVICE MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 291. CANADA GENE KNOCKDOWN SERVICE MARKET SIZE, BY ELECTROPORATION, 2018-2024 (USD MILLION)
TABLE 292. CANADA GENE KNOCKDOWN SERVICE MARKET SIZE, BY ELECTROPORATION, 2025-2030 (USD MILLION)
TABLE 293. CANADA GENE KNOCKDOWN SERVICE MARKET SIZE, BY LIPID-BASED TRANSFECTION, 2018-2024 (USD MILLION)
TABLE 294. CANADA GENE KNOCKDOWN SERVICE MARKET SIZE, BY LIPID-BASED TRANSFECTION, 2025-2030 (USD MILLION)
TABLE 295. CANADA GENE KNOCKDOWN SERVICE MARKET SIZE, BY VIRAL VECTOR, 2018-2024 (USD MILLION)
TABLE 296. CANADA GENE KNOCKDOWN SERVICE MARKET SIZE, BY VIRAL VECTOR, 2025-2030 (USD MILLION)
TABLE 297. CANADA GENE KNOCKDOWN SERVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 298. CANADA GENE KNOCKDOWN SERVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 299. CANADA GENE KNOCKDOWN SERVICE MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 300. CANADA GENE KNOCKDOWN SERVICE MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 301. CANADA GENE KNOCKDOWN SERVICE MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 302. CANADA GENE KNOCKDOWN SERVICE MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 303. CANADA GENE KNOCKDOWN SERVICE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 304. CANADA GENE KNOCKDOWN SERVICE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 305. CANADA GENE KNOCKDOWN SERVICE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 306. CANADA GENE KNOCKDOWN SERVICE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 307. CANADA GENE KNOCKDOWN SERVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 308. CANADA GENE KNOCKDOWN SERVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 309. CANADA GENE KNOCKDOWN SERVICE MARKET SIZE, BY BIOMARKER VALIDATION, 2018-2024 (USD MILLION)
TABLE 310. CANADA GENE KNOCKDOWN SERVICE MARKET SIZE, BY BIOMARKER VALIDATION, 2025-2030 (USD MILLION)
TABLE 311. CANADA GENE KNOCKDOWN SERVICE MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 312. CANADA GENE KNOCKDOWN SERVICE MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 313. CANADA GENE KNOCKDOWN SERVICE MARKET SIZE, BY FUNCTIONAL GENOMICS, 2018-2024 (USD MILLION)
TABLE 314. CANADA GENE KNOCKDOWN SERVICE MARKET SIZE, BY FUNCTIONAL GENOMICS, 2025-2030 (USD MILLION)
T

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Gene Knockdown Service Market report include:
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • QIAGEN N.V.
  • PerkinElmer, Inc.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • GenScript Biotech Corporation
  • Takara Bio Inc.
  • Azenta, Inc.

Related Topics

Related Reports

RNA Interference (RNAi) - Global Strategic Business Report - Product Image

RNA Interference (RNAi) - Global Strategic Business Report

  • Report
  • 178 Pages
  • Global
From
RNA-based Therapeutics - Global Strategic Business Report - Product Image

RNA-based Therapeutics - Global Strategic Business Report

  • Report
  • 274 Pages
  • Global
From
Antisense & RNAi Therapeutics Market Report 2025 - Product Image

Antisense & RNAi Therapeutics Market Report 2025

  • Report
  • 175 Pages
  • Global
From
RNA Interference Technology Market - Global Forecast 2025-2030 - Product Image

RNA Interference Technology Market - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
Antisense Oligonucleotide Therapeutics Market - Global Forecast 2025-2030 - Product Image

Antisense Oligonucleotide Therapeutics Market - Global Forecast 2025-2030

  • Report
  • 195 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.